ReviewIranian journal of public health2024

Efficacy and Safety of Autologous Cytokine-Induced Killer (CIK) Cellular Immunotherapy Combined with Chemotherapy in Non-Small-Cell Carcinoma (NSCLC): A Meta-Analysis.

Cheng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.